Thomas Gard

1.5k total citations
7 papers, 281 citations indexed

About

Thomas Gard is a scholar working on Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging and Reproductive Medicine. According to data from OpenAlex, Thomas Gard has authored 7 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Reproductive Medicine. Recurrent topics in Thomas Gard's work include Hypothalamic control of reproductive hormones (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Thyroid Disorders and Treatments (3 papers). Thomas Gard is often cited by papers focused on Hypothalamic control of reproductive hormones (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Thyroid Disorders and Treatments (3 papers). Thomas Gard collaborates with scholars based in United Kingdom, United States and Ireland. Thomas Gard's co-authors include P R Larsen, M Kaplan, Thomas E. Dick, Barry P. Markovitz, T A Poulton, Robert J. Norman, T. Chard, Roger Ekins, Kenneth Siddle and B. L. Brown and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Clinical Endocrinology & Metabolism and Endocrinology.

In The Last Decade

Thomas Gard

7 papers receiving 263 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Gard United Kingdom 6 156 79 55 30 28 7 281
A. Miyake Japan 12 68 0.4× 93 1.2× 115 2.1× 12 0.4× 15 0.5× 20 351
J.C. Calvo Spain 10 110 0.7× 76 1.0× 96 1.7× 18 0.6× 7 0.3× 15 322
Füsûn N. Zeytin United States 10 131 0.8× 112 1.4× 12 0.2× 19 0.6× 77 2.8× 18 314
L. A. Nolan United Kingdom 9 126 0.8× 56 0.7× 37 0.7× 13 0.4× 10 0.4× 13 234
Nobuhiro Nakatake Japan 6 193 1.2× 157 2.0× 35 0.6× 41 1.4× 65 2.3× 14 312
Nagambika Munaganuru United States 8 118 0.8× 69 0.9× 108 2.0× 47 1.6× 18 0.6× 8 454
E Mattar Brazil 12 187 1.2× 133 1.7× 46 0.8× 25 0.8× 5 0.2× 28 337
W Wang China 7 71 0.5× 183 2.3× 128 2.3× 18 0.6× 48 1.7× 11 387
J Herrera Mexico 9 169 1.1× 88 1.1× 92 1.7× 14 0.5× 2 0.1× 24 320
Karen Gray United States 10 39 0.3× 164 2.1× 37 0.7× 52 1.7× 72 2.6× 16 369

Countries citing papers authored by Thomas Gard

Since Specialization
Citations

This map shows the geographic impact of Thomas Gard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Gard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Gard more than expected).

Fields of papers citing papers by Thomas Gard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Gard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Gard. The network helps show where Thomas Gard may publish in the future.

Co-authorship network of co-authors of Thomas Gard

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Gard. A scholar is included among the top collaborators of Thomas Gard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Gard. Thomas Gard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Bibby, David C., et al.. (2003). Encapsulation of recombinant hepatitis B surface antigen in oligosaccharide ester derivatives by spray drying. Journal of Microencapsulation. 20(6). 759–766. 1 indexed citations
2.
Norman, Robert J., T A Poulton, Thomas Gard, & T. Chard. (1985). Monoclonal Antibodies to Human Chorionic Gonadotropin: Implications for Antigenic Mapping, Immunoradiometric Assays, and Clinical Applications**. The Journal of Clinical Endocrinology & Metabolism. 61(6). 1031–1038. 43 indexed citations
3.
Soos, Maria A., et al.. (1984). A rapid, sensitive two-site immunometric assay for TSH using monoclonal antibodies: Investigation of factors affecting optimisation. Journal of Immunological Methods. 73(2). 237–249. 21 indexed citations
4.
Siddle, Kenneth, Thomas Gard, Thomas Deffieux, Martin Cranage, & R.R.A. Coombs. (1984). Red cell-labelled monoclonal antibodies for assay of human chorionic gonadotropin and luteinising hormone by reverse passive haemagglutination. Journal of Immunological Methods. 73(1). 169–176. 23 indexed citations
5.
Gard, Thomas, et al.. (1981). Studies on the Mechanism of 3,5,3′-Triiodothyronine-Induced Suppression of Secretagogue-Induced Thyrotropin Releasein Vitro*. Endocrinology. 108(6). 2046–2053. 17 indexed citations
6.
Larsen, P R, Thomas E. Dick, Barry P. Markovitz, M Kaplan, & Thomas Gard. (1979). Inhibition of intrapituitary thyroxine to 3.5.3'-triiodothyronine conversion prevents the acute suppression of thyrotropin release by thyroxine in hypothyroid rats.. Journal of Clinical Investigation. 64(1). 117–128. 127 indexed citations
7.
Brown, B. L., et al.. (1978). Effect of TRH and dopamine on cyclic AMP levels in enriched mammotroph and thyrotroph cells. Molecular and Cellular Endocrinology. 12(3). 273–284. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026